Surgical Treatment of Concomitant Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Why Are We Not Following the Guidelines?
* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
In this annual Michael DeBakey Lecturer in Cardiac Surgery presentation, Dr. Ralph Damiano discusses the clinical burden of atrial fibrillation and its management options, particularly within the framework of care plans for patients with valvular disease.
This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, January 24, 2024 at 7:00 a.m.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
Surgeons, advanced practice providers, fellows, residents, and medical students in various surgical specialties and subspecialties need to receive regular updates on advances in surgical care and clinical practices. Novel technologies and procedures will be examined as means to improve the diagnosis and treatment of medical conditions requiring surgical intervention. The series aims to expand the knowledge of learners, enhance surgical skills, increase surgical efficiency, disseminate surgical best practices, and improve surgical outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Discuss the evidence supporting the safety and efficacy of surgical ablation of atrial fibrillation (AF) in patients undergoing mitral valve procedures.
- List the late benefits of treating AF in patients undergoing concomitant surgery.
- Summarize why all patients with AF undergoing any cardiac procedure should have their left atrial appendage excluded.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Cardiology
- Surgery
Interest Groups
- Hospital Medicine
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Lectures
- Case Presentations
- Literature Review
- Panel Discussion
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
-
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Term of Approval
January 1, 2024 through January 31, 2026. Original release date: January 1, 2024.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Ralph Damiano, M.D.
Professor and Chief, Evarts A. Graham Division of Cardiothoracic Surgery
Washington University School of Medicine
Disclosure:
Nothing to disclose.
Activity Directors
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
- Research Support: Abbvie
- Consultancy: Vicarious Surgical
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Mass Spec Pen Technologies
- Board Membership: Mass Spec Pen Technologies; Inspectra Diagnostics
Planning Committee Members
-
William E Fisher, M.D., FACS
Professor, Clinical Vice-Chair and Chief, Division of General Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Scott A. LeMaire, MD, FACS, FAHA, FCCP
Professor and Vice-Chair for Research
Baylor College of Medicine
Disclosure:
- Research Support: Terumo Aortic; CytoSorbents, Inc.
- Advisory Committee Membership: Cerus
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
- Research Support: Abbvie
- Consultancy: Vicarious Surgical
-
Todd Rosengart, M.D., F.A.C.S.
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: XyloCor
- Board Membership: XyloCor; Geoclin
- Ownership Interests (stock, stock options, excluding diversified mutual funds): XyloCor; Geoclin
-
Jeffrey Alan Ross, D.P.M, M.D.
Associate Professor of Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Smith & Nephew; Lifenet Health
- Honorarium Recipient: Smith & Nephew; Lifenet Health
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Mass Spec Pen Technologies
- Board Membership: Mass Spec Pen Technologies; Inspectra Diagnostics
Health Topics
Presenter:
![Ralph Damiano, M.D. Ralph Damiano, M.D.](https://static.clinicianresources.bcm.edu/media/rdamiano.jpg)